Evidence map›Paper›PMID 39206882›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Spin-Flip-Restricted Multiple-Resonance Emitters for Extended Device Lifetime in Indolocarbazole-Based Blue Organic Light-Emitting Diodes.

Jihoon Kang, Ha Lim Lee, Soon Ok Jeon, Hye Jin Bae, Seung Chan Kim, Seungwon Han, Jun Yeob Lee

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jihoon KangSchool of Chemical Engineering, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon, Gyeonggi, 16419, Republic of Korea.
Ha Lim LeeSchool of Chemical Engineering, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon, Gyeonggi, 16419, Republic of Korea.
Soon Ok JeonSamsung Advanced Institute of Technology, Samsung Electronics Co., Ltd, 130 Samsung-ro, Yeongtong-gu, Suwon, Gyeonggi, 16678, Republic of Korea.
Hye Jin BaeSamsung Advanced Institute of Technology, Samsung Electronics Co., Ltd, 130 Samsung-ro, Yeongtong-gu, Suwon, Gyeonggi, 16678, Republic of Korea.
Seung Chan KimSchool of Chemical Engineering, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon, Gyeonggi, 16419, Republic of Korea.
Seungwon HanDepartment of Display Convergence Engineering, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon, Gyeonggi, 16419, Republic of Korea.
Jun Yeob LeeSchool of Chemical Engineering, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon, Gyeonggi, 16419, Republic of Korea.ORCID https://orcid.org/0000-0002-7677-0605

Funding

MOTIE 20018956National Research Foundation of Korea NRF-2020R1A2C2100872Samsung Advanced Institute of Technology
6 · The paper itself

Abstract

In this study, a multiple-resonance (MR) core structure is developed with a spin-flip-restricted emission mechanism based on a fused indolo[3,2,1-jk]carbazole (ICz) framework as emitters to improve the lifetime of blue organic light-emitting diodes. The molecular skeleton modulation approach applied to the conjugated π-system effectively stabilizes the triplet energy of the fused ICz emitters and narrows the full-width-at-half maximum (<20 nm). In addition, the emitters exhibit higher exciton stability than conventional boron-based MR emitters. The fused ICz-based blue fluorescent device exhibits a high external quantum efficiency of 7.2%, a blue index of 68.6 cd A

Indexed as

blue emitterdevice lifetimefluorescencemultiple‐resonance effectnarrow emission

Identifiers

PMID39206882
PMCPMC11515912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.